Speaker illustration

Professor Timothy McKinsey

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

Dr. McKinsey is a Professor in the Department of Medicine/Division of Cardiology at the University of Colorado Anschutz Medical Campus in Denver, where he holds the Joseph and Rose LaConte Cardiology Endowed Chair. Dr. McKinsey is also Associate Division Head for Translational Research and Director of the university’s Consortium for Fibrosis Research & Translation (CFReT; www.cfret.org). He obtained a PhD in Microbiology and Immunology from Vanderbilt University School of Medicine, studying NF-kB signaling in the laboratory of Dr. Dean Ballard. Dr. McKinsey’s postdoctoral training was done in the laboratory of Dr. Eric Olson at the University of Texas Southwestern Medical Center in Dallas, where he investigated transcriptional control of muscle development and growth. The current interests of Dr. McKinsey’s lab include defining epigenetic mechanisms controlling heart failure with preserved ejection fraction (HFpEF).

Targeting histone deacetylases.

Event: Heart Failure 2022

Topic: Heart Failure

Session: New targets for the treatment of heart failure with preserved ejection fraction

Thumbnail

Epigenetic therapies for heart failure.

Event: ESC Congress 2020

Topic: Basic Science

Session: Epigenetic Drugs: Targeting the ‘Heart’ of Cardiovascular Remodeling

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb